Literature DB >> 2850174

A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target.

N Dostatni1, F Thierry, M Yaniv.   

Abstract

The E2 proteins encoded by papillomaviruses interact with the viral DNA to regulate its transcription. In the present study, we have constructed bacterial vectors expressing the full-length or N-terminal truncated BPV-1 E2 proteins under the control of an inducible promoter. By UV cross-linking experiments we show that a dimer of the intact or truncated E2 protein interacts with a single palindromic site ACCGNNNNCGGT. The DNA-binding domain of E2 can be reduced to a small protease resistant core. Methylation interference studies show that this C-terminal domain interacts with the major groove of the DNA by contacting two consecutive guanine residues in both halves of the palindrome. Although one binding site is sufficient for high affinity binding in vitro or in vivo, two E2 binding sites are required for transcriptional activation in eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850174      PMCID: PMC454957          DOI: 10.1002/j.1460-2075.1988.tb03265.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18.

Authors:  D Gius; S Grossman; M A Bedell; L A Laimins
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Photochemical addition of amino acids to 14C-uracil.

Authors:  K C Smith
Journal:  Biochem Biophys Res Commun       Date:  1969-02-07       Impact factor: 3.575

3.  Two Shope papillomavirus-associated VX2 carcinoma cell lines with different levels of keratinocyte differentiation and transplantability.

Authors:  E Georges; F Breitburd; N Jibard; G Orth
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

4.  The operator-binding domain of lambda repressor: structure and DNA recognition.

Authors:  C O Pabo; M Lewis
Journal:  Nature       Date:  1982-07-29       Impact factor: 49.962

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

7.  The mac promoters: functional hybrid promoters activated by the malT product and repressed by the lacI product.

Authors:  D Vidal-Ingigliardi; O Raibaud
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

8.  Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication.

Authors:  E Remaut; H Tsao; W Fiers
Journal:  Gene       Date:  1983-04       Impact factor: 3.688

9.  A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system.

Authors:  M M Garner; A Revzin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

10.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.

Authors:  M Boshart; L Gissmann; H Ikenberg; A Kleinheinz; W Scheurlen; H zur Hausen
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  53 in total

1.  Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro.

Authors:  A A McBride; R D Klausner; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Molecular dynamics studies on free and bound targets of the bovine papillomavirus type I e2 protein: the protein binding effect on DNA and the recognition mechanism.

Authors:  D Djuranovic; B Hartmann
Journal:  Biophys J       Date:  2005-07-29       Impact factor: 4.033

3.  The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops.

Authors:  J D Knight; R Li; M Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences.

Authors:  P Monini; S R Grossman; B Pepinsky; E J Androphy; L A Laimins
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis.

Authors:  C Desaintes; C Demeret; S Goyat; M Yaniv; F Thierry
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

6.  Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance.

Authors:  F Thierry; N Dostatni; F Arnos; M Yaniv
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity.

Authors:  D J Riese; J Settleman; K Neary; D DiMaio
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1.

Authors:  A A McBride; J B Bolen; P M Howley
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements.

Authors:  C M Sanders; N J Maitland
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

10.  Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter.

Authors:  B A Spalholz; S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.